Lenz Therapeutics, Inc. · NASDAQ:LENZ

Paradigm Biocapital Advisors LP reported a 5.20% stake in Lenz Therapeutics, Inc. (Schedule 13G)

Event Mar 20, 2025 · Filed Mar 27, 2025

Paradigm Biocapital Advisors LP reported a 5.20% stake in Lenz Therapeutics, Inc., 1,419,832 shares, as a passive investor on Mar 20, 2025. Filed Mar 27, 2025 (Schedule 13G).

Stake
5.20%
Shares
1,419,832
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.20%1,419,832
Paradigm BioCapital Advisors GP LLC5.20%1,419,832
Senai Asefaw, M.D.5.20%1,419,832
Paradigm BioCapital International Fund Ltd.4.60%1,254,521

Source

View original at SEC

Related